The second largest integrated delivery and financing network in the nation, Highmark Health, today announced that through its VITAL Innovation Program, it will be evaluating WellDoc’s® BlueStar
The results of this evaluation could yield further evidence that may accelerate BlueStar’s coverage and utilization by Highmark Health and its affiliated clinicians and health plans—fast-tracking BlueStar to patients who could benefit from the digital therapeutic.
Available on smartphones and via a web version, WellDoc’s BlueStar mobile app is a digital health coach that uniquely engages with people with type 2 diabetes and delivers personalized, real-time feedback, as well as personalized diabetes educational tools. It connects adults living with type 2 diabetes, their health care team members, and payers through enhanced communication and support. Clinical evidence shows a 1.7 to 2.0 mean A1C reduction for adults living with type 2 diabetes who use BlueStar.
“This evaluation of BlueStar, in conjunction with Allegheny Health Network and Highmark Health’s VITAL program, stands to demonstrate the power of a clinically-proven digital therapeutic to improve health outcomes and to lower costs of treatment,” said Kevin McRaith, WellDoc president and CEO.